ADA and dQ&A survey results reveal that COVID fears kept one in five people with diabetes away from the doctor during the pandemic.
Our latest work examines the real-world psychosocial impact of Automated Insulin Delivery (AID) systems, analyzing user experiences, quality of life, and daily diabetes burden.
This article reports results of a survey of patients and health care providers regarding their experiences of and challenges with the use of basal insulin.
.png)
